The Democratic Republic of Congo confirmed the presence of the Indian coronavirus strain on its territory as five cases of the variant have been reported in Kinshasa.
Nonetheless, the Minister of Health Jean-Jacques Mbungani Mbanda urges the Congolese to remain calm.
"Among the 25 positive cases, there are five Indian variants, the result of a double mutation of the British variant and the South African variant. But the situation is calm, at the clinical level, there is also no fear, so the population should be reassured because all measures have been taken."
In the meantime, the country announced at the end of April that it had "redeployed" 1.3 million "surplus" AstraZeneca vaccines to five neighbouring countries. The health ministry admitted that some sections of the population had simply refused to have the jab.
The rest of Africa is watching aghast as India struggles with coronavirus, fearing a long-running shortfall in the Indian-made vaccines that it needs to help shield its people.
Often dubbed the "world's pharmacy", India is one of the biggest suppliers of the AstraZeneca vaccine under the Covax programme to help immunisation in poorer countries.
But India has been hammered by an explosive growth in infections -- accelerated, say scientists, by a new variant.
The country has recorded 22 million cases out of a population of 1.3 billion, inflicting a death toll of nearly a quarter of a million.
After sending more than 60 million doses abroad, India announced at the end of March that it was delaying overseas supplies as it works to meet its own needs.
It was a lonely battle last October when South Africa and India first proposed a temporary waiver on COVID patents. Since then, more than 100 countries have joined the proposal -- and today the Biden administration gave the crucial support of the United States. https://t.co/20TeqvtUxz
— Geoffrey York (@geoffreyyork) May 5, 2021
India and South Africa last year requested for the upliftment of patent rights of vaccine as a way of boosting manufacturing and ensuring the world is supplied. But the european union is still sceptical about the usefulness of waving patent rights to COVID-19 vaccines.#COVID
— Devanshi Samnotra (@DSamnotra) May 9, 2021
Yesterday @LeoVaradkar stated the following in relation to the #TRIPSwaiver - “very few countries in the global south have the infrastructural know-how or the materials to make those vaccines." We wish to share the following to add to this debate-THREADhttps://t.co/QtOGuZSPEK
— Oxfam Ireland (@OxfamIreland) May 7, 2021
When I say the US should do more to vaccinate the world, someone always says ‘do these countries even have the cold storage capacity for these vaccines?!?!’
— Craig Spencer MD MPH (@Craig_A_Spencer) May 4, 2021
A reminder that Congo, Burundi and South Sudan all used Ebola vaccine at -70C. Long before Covid.https://t.co/uJGcTGqdpW
So according to the much celebrated global media outlets, the Corona variants are Brazil variant, South Africa variant, UK variant, India variant and so on, but the original virus is just Covid. Not Chinese. Let that sink in.
Well played China. Well played.
— Yashwant Deshmukh ???????? (@YRDeshmukh) May 10, 2021